Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy manufacturing
Manufacturing
With ‘lessons learned,’ Kite preps for key CAR-T launch
Gilead's Kite is preparing to hit the ground running with the potential approval of a next-generation multiple myeloma cell therapy later this year.
Fraiser Kansteiner
Apr 28, 2026 11:30am
Astellas manufacturing chief talks strategy 1 year into role
Apr 15, 2026 10:35am
FDA delays decision on Orca Bio’s cell therapy for blood cancers
Apr 1, 2026 8:00am
AZ to build cell therapy supply hub, R&D center in Shanghai
Mar 19, 2026 10:20am
Fierce Biotech
Charles River sells CDMO and discovery assets in strategic pivot
Feb 25, 2026 1:54pm
In another round of layoffs in Maryland, Catalent cuts 96 roles
Feb 20, 2026 2:49pm
